Atrium Health - Company Profile
Powered by 
All the sales intelligence you need on Atrium Health in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Atrium Health fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Atrium Health.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Atrium Health Catalyst Calendar
Proactively evaluate Atrium Health’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Atrium Health Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Jul 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Jun 2020 | Phase II Trial Completion | Atrium Health; Carolina Neurosurgery & Spine Associates PA; Nutech Medical Inc; Organogenesis Holdings Inc | ORGO | human amniotic tissue-derived allograft | Central Nervous System; Musculoskeletal Disorders | Degenerative Disc Disease; Degenerative Spondylolisthesis; Spinal Stenosis; Spondylitis | Clinical Trial Registry |
| 01 Jun 2020 | Phase II Trial Initiation | Atrium Health; Beat Nb Cancer Foundation Inc; KC Pharma LLC; Team Parker for Life | - | eflornithine | Oncology | Neuroblastoma | Clinical Trial Registry |
| 15 Apr 2020 | Phase I/II Trial Initiation | Atrium Health; Beth Israel Deaconess Medical Center; Bristol-Myers Squibb Co; Dana-Farber Cancer Institute Inc; Emory University; Hackensack Meridian Health; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Multiple Myeloma Research Consortium LLC; University of Michigan; University of Texas at Austin; Washington University School of Medicine | BMY | BMS-986207; pomalidomide; relatlimab | Oncology | Multiple Myeloma (Kahler Disease); Refractory Multiple Myeloma; Relapsed Multiple Myeloma | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer